Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lama

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 StudyRaphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, et al.
The New England Journal of Medicine|November 25, 2010
Preexposure chemoprophylaxis for HIV prevention in men who have sex with menRobert M Grant, Javier R Lama, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Prevalences, genotypes, and risk factors for HIV transmission in South AmericaSilvia M Montano, Jose L Sanchez, Alberto Laguna-Torres, et al.
Communications Medicine|April 17, 2026
Viral variant but not host factors associate with SARS-CoV-2 viral kineticsWilliam O Hahn, Leigh H Fisher, Amy Ward, et al.
The New England Journal of Medicine|March 17, 2021
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Peter B Gilbert, Michal Juraska, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2016
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% GelRoss D Cranston, Javier R Lama, Barbra A Richardson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 StudyRaphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, et al.
The New England Journal of Medicine|November 25, 2010
Preexposure chemoprophylaxis for HIV prevention in men who have sex with menRobert M Grant, Javier R Lama, Peter L Anderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Prevalences, genotypes, and risk factors for HIV transmission in South AmericaSilvia M Montano, Jose L Sanchez, Alberto Laguna-Torres, et al.
Communications Medicine|April 17, 2026
Viral variant but not host factors associate with SARS-CoV-2 viral kineticsWilliam O Hahn, Leigh H Fisher, Amy Ward, et al.
The New England Journal of Medicine|March 17, 2021
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 AcquisitionLawrence Corey, Peter B Gilbert, Michal Juraska, et al.
Pageof 23